How protein-based COVID vaccines could change the pandemic
Elie Dolgin • November 8, 2021
Jabs from Novavax and other biotech firms are coming. Scientists say they have a lot to offer.
Continue reading at Nature.
Fresh treatments shift the focus from symptom management to repair.
Smart algorithms take aim at antimicrobial resistance.